-+ 0.00%
-+ 0.00%
-+ 0.00%

Market Chatter: Novo Shareholders Reportedly Request New Medicine Developments, Acquisitions

MT Newswires·09/20/2026 05:20:21
Listen to the news
05:20 AM EDT, 09/20/2026 (MT Newswires) -- Novo Nordisk's (NOVO-B.CO) shareholders are said to have requested for new acquisitions and the development of new drugs to grow its portfolio, London's Financial Times reported Sunday. The shareholders added that their proposal reportedly aims to help reduce the Danish drugmaker's reliance on its weight-loss treatment assets, as well as protect the company from revenue loss. Novo Nordisk did not immediately respond to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)